Happiest Minds to build AI, ML-based predictive health platform for client

“The significant advancements in engineering and data sciences, along with enhanced computational capabilities, have ushered in new possibilities beyond traditional medical science-based preventive and diagnostic approaches,” the company said in a press release. “Instead, there's a shift towards innovative technology-driven "interceptive" solutions. This project seeks to deliver precise mapping of individuals' physiology, facilitating a highly-nuanced comprehension of health, wellness, and aging on an individual level.”

Happiest Minds, with its technology, bioinformatics, and data science expertise, has been chosen by MindSculpt Analytics to build this preventive & diagnostics platform.

The focus of the current engagement is to build a holistic health portrait of the individual and over time use this for an early and accurate diagnosis and personalized treatments of multiple ailments that include a range of age and neuro-related diseases, Happiest Minds said, adding that the health portrait will be equipped to track post-disease recovery also.

“MindSculpt Analytics spearheads the creation of innovative approaches to analyzing complex data, harnessing the full potential of cutting-edge technology and advanced computational tools across various fields,” said Dr Paul Salins, Founder & CEO, MindSculpt Analytics.

The future of healthcare is shifting from traditional disease-focused and physician-dependent medical strategies to predictive auto-diagnostics led by technology and focusing on the dynamics of personal wellness, Salins added.

“Our goal is to revolutionize the acquisition of individual-specific health data, tailored for the latest advancements in data science and computational resources, enabling early prediction and measurement of health indicators, disease progression, and treatment responses,” he said.

“We are delighted to have the opportunity to execute this highly significant project for MindSculpt Analytics,” Ashok Soota, Executive Chairman of Happiest Minds. “I am also pleased that the capabilities we are building in Happiest Minds are creating a unique position to provide innovative bioinformatics and hardware solutions for the market as forerunners in a space with enormous market potential in the domain of medical research.”

Happiest Minds shares were down 2% in afternoon trade at ₹806. Following its IPO in September 2020, the stock rose more than 4X from about ₹350 to nearly ₹1,500 in July 2021 but have corrected nearly 50% from all time high levels of ₹1580 .